(1) Background: Alanine aminotransferase (ALT) is used to screen for non-alcoholic fatty liver disease (NAFLD) in children; however, the optimal age to commence screening is not determined. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.